R66-35-5. Label Requirements

(1) A cannabinoid product label shall legibly display the following information: (a) product name or common name, on the front of the label; (b) brand name, on the front of the label; (c) the size of the container or net count of individual items, on the front of the label; (d) the suggested use of the product, including serving size if the product is intended for consumption; (e) list of ingredients, including: (i) the amount of any advertised cannabinoid listed as present on the COA; and (ii) the amount of any THC or any THC analog listed as present on the COA; (f) manufacturer, packer, or distributor name and address, as verified through the application; and (g) batch number. (2) The label of each product intended for human consumption shall include the following text, prominently displayed: "This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." or a similar statement. (3) In addition to the requirements of Subsections R66-35-5(1) through R66-35-5(5), a cannabinoid product label shall include a scannable barcode, QR code, or web address with an easily located COA for the batch identified, containing the information required in Section R66-35-4. (4) Cannabinoid product labeling may not: (a) have any likeness bearing resemblance to a cartoon character or fictional character; or (b) appear to imitate a food or other product that is typically marketed toward or appealing to children. (5) A cannabinoid product is misbranded if its label is false or misleading in any way.